SHAREHOLDER ALERT: WeissLaw LLP Investigates BioDelivery Sciences International, Inc.

NEW YORK, Feb. 15, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioDelivery Sciences International, Inc. ("BioDelivery" or the "Company") (NASDAQ: BDSI), in connection with the proposed acquisition of the Company by Collegium Pharmaceutical, Inc. ("Collegium") (NASDAQ: COLL) via a tender offer.  Under the terms of the acquisition agreement, the Company's shareholders will receive $5.60 in cash for each share of BioDelivery common stock that they hold.  The transaction is valued at approximately $604 million.